NSRX Nasus Pharma Ltd: Company Short-Term Debt

Corporate emblem and logo of Nasus Pharma (NSRX)

Pressure risks from pharma behemoths are impacting the credit profile of Nasus Pharma Ltd (NSRX). Short-term debt capital, which the GURU.Markets system illustrates in this chart, demonstrates stability, with the indicator settling at 0.00. Financial stability is based on the external outsourcing of powder spray production and support via partnership grants, which mitigates dependence on insurance approval timelines for the systems.

Nasus Pharma, Ltd. (NSRX) - Company Short-Term Loans and Borrowings from 08/14/2025 to 10/29/2026

Summary analytical data breakdowns for Nasus Pharma Ltd. (NSRX)

- stock price and consensus target price:
Stock Price Nasus Pharma, Ltd.|NSRX - Consensus Target
- company stock capitalization data:
Market Value Nasus Pharma Ltd|NSRX - Total Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share Nasus Pharma|NSRX - Accounting Value of Company|Market Capitalization to Book Value Ratio nasuspharma.com|NSRX - Total Asset Value of Company
- debt and liquidity details:
Total Debt to Capital Nasus Pharma Ltd|NSRX - Long-Term Debt to Capital|Short-Term Debt to Equity Nasus Pharma, Ltd.|NSRX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Nasus Pharma Ltd|NSRX - Company Long-Term Liabilities|Company Short-Term Debt Nasus Pharma|Quick Ratio nasuspharma.com
- earnings and valuation multiples indicators:
NSRX - Net Profit
General company analysis:NSRX - nasuspharma.com
Manufactured products of Nasus Pharma, Ltd.

Short-term debt measures the total credit obligations maturing within one year, determining the issuer's ability to maintain operational liquidity without the risk of default. By analyzing financial debt with a maturity of up to 12 months, an investor assesses the efficiency of working capital management, which is critical for Nasus Pharma Ltd (NSRX) when servicing costly automated production lines for nasal medications.

Competitor analysis

Indivior - Company Short-Term Debts|Collegium Pharma (COLL) - Company Current Liabilities|Cronos (CRON) - Company Short-Term Debt|Short-Term Debt Canopy Growth Corp. (CGC)|Company Current Liabilities HITI|ACB: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACHV|SKYE: Current Liabilities|Company Short-Term Debts ANEB (Anebulo)|Company Short-Term Debts InterCure Ltd INCR|NTRB - Company Short-Term Debt|Company Short-Term Loans and Borrowings IGC (IGC Pharma, Inc.)|mirapharmaceuticals.com (MIRA) - Company Short-Term Debt|Company Current Liabilities Flora Growth Corp|Company Short-Term Debt IM Cannabis Corp|Company Short-Term Indebtedness ADIL (Adial)|Company Short-Term Debts ARTL|Company Short-Term Debts ensysce.com (ENSC)|Company Short-Term Debt Titan Pharmaceuticals, Inc. TTNP|Short-Term Debt Volume Greenlane Holdings, Inc. (GNLN)|INM: Company Current Liabilities|AKAN - Company Short-Term Debts|Enveric Biosciences (ENVB) - Company Short-Term Debt|BGXX - Short-Term Debt Volume|Company Current Liabilities HPCO